Dr Anil Kumar Deshanri has completed his PhD in 2018 from University Medical Center Utrecht, The Netherlands. He is working as a Scientis Pre-Clinical Pharmacology at Sun Pharma Advanced Research Company Limited, a leading pharmaceutical company in India. He has published 8 papers in reputed journals and has more than 12 years of research experience in industry and academia. His research interest is to establish advanced animal models for cancer research and to develop nanomedicine drug delivery systems for cancer and inflammatory disorders